Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
11.04
10.52
95.29%
Share Warrants & Outstandings
Total Reserve
-184.32
121.96
-306.28
-251.13%
Shareholder's Funds
-162.75
133.00
-295.75
-222.37%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
163.55
0.00
163.55
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
163.55
0.00
163.55
0.00%
Deferred Tax Assets / Liabilities
0.00
1.33
-1.33
-100.00%
Other Long Term Liabilities
45.00
1.86
43.14
2,319.35%
Long Term Trade Payables
1.61
0.00
1.61
0.00%
Long Term Provisions
2.78
0.25
2.53
1,012.00%
Total Non-Current Liabilities
212.94
3.44
209.50
6,090.12%
Current Liabilities
Trade Payables
13.76
17.98
-4.22
-23.47%
Other Current Liabilities
37.32
4.31
33.01
765.89%
Short Term Borrowings
61.29
33.44
27.85
83.28%
Short Term Provisions
0.70
0.00
0.70
0.00%
Total Current Liabilities
113.07
55.73
57.34
102.89%
Total Liabilities
163.25
192.17
-28.92
-15.05%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.01
42.07
271.94
646.40%
Less: Accumulated Depreciation
172.30
0.70
171.60
24,514.29%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
141.71
41.37
100.34
242.54%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.59
0.00
1.59
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
79.51
-79.51
-100.00%
Long Term Loans & Advances
10.33
0.29
10.04
3,462.07%
Other Non Current Assets
0.00
0.40
-0.40
-100.00%
Total Non-Current Assets
153.62
121.57
32.05
26.36%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.70
0.00
5.70
0.00%
Sundry Debtors
0.00
64.20
-64.20
-100.00%
Cash and Bank
0.13
5.33
-5.20
-97.56%
Other Current Assets
0.35
0.99
-0.64
-64.65%
Short Term Loans and Advances
3.43
0.08
3.35
4,187.50%
Total Current Assets
9.62
70.60
-60.98
-86.37%
Net Current Assets (Including Current Investments)
-103.44
14.87
-118.31
-795.63%
Total Current Assets Excluding Current Investments
9.62
70.60
-60.98
-86.37%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
163.25
192.17
-28.92
-15.05%
Contingent Liabilities
10.26
0.00
10.26
0.00%
Total Debt
224.84
33.44
191.40
572.37%
Book Value per share (adjusted)
-75.49
24.09
-99.58
-413.37%
Annual - Borrowings
Borrowings 224.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 143.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 9.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025
Footer loading
